The New York-based startup is focused on using AI to accurately predict not only if a patient has cancer, but also what their ...

Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX ...

Ataraxis AI will use the new funding to bring to market its first offering, Ataraxis Breast, an AI-native prognostic/predictive platform for breast cancer.

This story has been updated to note that the Trump administration appears to have reversed a number of planned CDRH staffing cuts, including to reviewers hired with funding provided by industry user ...

We all know headphones can be bad for your hearing if you listen to sounds too loudly in close proximity to your ears. But a BBC report suggests that a new health scare could be emerging around ...

NEW YORK – Galapagos said Monday that it has partnered with NecstGen, a contract development and manufacturing organization (CDMO), to support decentralized manufacturing of Galapagos' cell therapy ...

NEW YORK – Cancer diagnostics firm Imagene on Wednesday announced that it is collaborating with Tempus AI to launch an AI-based biomarker prediction panel for non-small cell lung cancer. Imagene's ...